Fresenius Medical Care saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 78 to 81.
Looking For The Best Stocks To Buy And Watch? Start Here
This exclusive rating from Investor's Business Daily tracks market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the last 52 weeks holds up against all the other stocks in our database.
History shows that the stocks that go on to make the biggest gains typically have an RS Rating of above 80 in the early stages of their moves.
Fresenius Medical Care is working on a flat base with a 30.46 buy point. See if it can clear the breakout price in heavy trading.
Earnings growth dropped last quarter from 62% to 25%. But revenue gains moved higher, from -4% to 4%. Look for the next report on or around Aug. 5.
The company holds the No. 3 rank among its peers in the Medical-Outpatient/Home Care industry group. BrightSpring Hlth Svcs is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
